Advertisement
Demo

Sanofi drug Dupixent wins FDA approval to treat asthma

Oct 20, 2018 , Reuters
France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.


Read the full story...


Trending healthcare news keywords at this moment

medicaid women cancer medicare researchers healthcare drug birth control launches pharma lung patients study disease food found flu state hospital care opioid save life tied sleep growth cvs ceo global digital tech doctors pain generic report americans marketing fda shutdown risk diabetes kids shows tip treatment year change data walmart type